Pinteon Therapeutics Announces $3 Million Award
17 Jun 2021 //
BUSINESSWIRE
Pinteon Announces $3 Million Award to Support Phase 1 Study of PNT001
16 Jun 2021 //
BUSINESSWIRE
Pinteon Therapeutics Announces First Patient Dosed in Phase 1 Study of PNT001
06 Apr 2021 //
BUSINESSWIRE
Pinteon Announces First Patient Dosed in Phase 1 Study of PNT001
06 Apr 2021 //
BUSINESSWIRE